Some studies have shown an association between higher levels of phosphorylated Tau at threonine 181 (p-Tau) and/or lower amyloid-beta 1–42 (Aβ42) levels and worse cognitive decline [35,36]. The gene discussed is MAPT; the disease is Mental deterioration.